Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis

Ophthalmology

Volumn 121, Issue 8, 2014, Pages 1649-1654

  Tomkins Netzer, Oren ^a,b,c   Taylor, Simon R J ^c,d   Bar, Asaf ^a,b,c   Lula, Albert ^c   Yaganti, Satish ^c   Talat, Lazha ^a,b   Lightman, Sue ^a,b,c  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Abbreviations and Acronyms; BCVA; best corrected visual acuity; central retinal thickness; CME; CRT; cystoid macular edema; intraocular pressure; IOP; logarithm of the minimum angle of resolution; logMAR

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; ARTICLE; CATARACT; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; IMPLANT; INTERMEDIATE UVEITIS; INTRAOCULAR PRESSURE ABNORMALITY; LONG TERM CARE; MALE; PRIORITY JOURNAL; RETINA MACULA EDEMA; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY; VITREOUS BODY; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG IMPLANT; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MACULAR EDEMA; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHYSIOLOGY; RETINA; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

CATARACT; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RETINA; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITREOUS BODY;

EID: 84905444772     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.02.003     Document Type: Article

References (24)

1. M.D. de Smet, S.R. Taylor, and B. Bodaghi et al. Understanding uveitis: the impact of research on visual outcomes Prog Retin Eye Res 30 2011 452 470
2. O. Tomkins-Netzer, S.R. Taylor, and S. Lightman Corticosteroid-sparing agents: new treatment options Dev Ophthalmol 51 2012 47 56
3. A.K. McDonough, J.R. Curtis, and K.G. Saag The epidemiology of glucocorticoid-associated adverse events Curr Opin Rheumatol 20 2008 131 137
4. A. Sallam, S.R. Taylor, and S. Lightman Review and update of intraocular therapy in noninfectious uveitis Curr Opin Ophthalmol 22 2011 517 522
5. Z. Habot-Wilner, A. Sallam, and A. Roufas et al. Periocular corticosteroid injection in the management of uveitis in children [report online] Acta Ophthalmol 88 2010 e299 e304
6. H. Kok, C. Lau, and N. Maycock et al. Outcome of intravitreal triamcinolone in uveitis Ophthalmology 112 2005 1916 1921
7. S.R. Taylor, H. Isa, L. Joshi, and S. Lightman New developments in corticosteroid therapy for uveitis Ophthalmologica 224 suppl 2010 46 53
8. Y. Tao, and J.B. Jonas Intravitreal triamcinolone Ophthalmologica 225 2011 1 20
9. S. Young, G. Larkin, M. Branley, and S. Lightman Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis Clin Experiment Ophthalmol 29 2001 2 6
10. B. van Kooij, A. Rothova, and P. de Vries The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema Ocul Immunol Inflamm 14 2006 73 85
11. K.M. Sampat, and S.J. Garg Complications of intravitreal injections Curr Opin Ophthalmol 21 2010 178 183
12. M.C. Gillies, J.M. Simpson, and F.A. Billson et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial Arch Ophthalmol 122 2004 336 340
13. M.D. de Smet Corticosteroid intravitreal implants Dev Ophthalmol 51 2012 122 133
14. D.S. Friedman, J.T. Holbrook, H. Ansari MUST Research Group Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the Multicenter Uveitis Steroid Treatment Trial Ophthalmology 120 2013 1571 1579
15. The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Writing Committee, J.H. Kempen, M.M. Altaweel, and J.T. Holbrook et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment Trial Ophthalmology 118 2011 1916 1926
16. C.C. Patel, N. Mandava, and S.C. Oliver et al. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert) Retina 32 2012 537 542
17. J.A. Haller, F. Bandello, R. Belfort Jr. Ozurdex Geneva Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
18. J.A. Haller, F. Bandello, and R. Belfort Jr. et al. Ozurdex Geneva Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results Ophthalmology 118 2011 2453 2460
19. C. Lowder, R. Belfort Jr., S. Lightman Ozurdex Huron Study Group Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis Arch Ophthalmol 129 2011 545 553
20. E. Moisseiev, M. Goldstein, and M. Waisbourd et al. Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion Eye (Lond) 27 2013 65 71
21. C.A. Arcinue, O.M. Ceron, and C.S. Foster A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis J Ocul Pharmacol Ther 29 2013 501 507
22. S.R. Taylor, O. Tomkins-Netzer, and L. Joshi et al. Dexamethasone implant in pediatric uveitis [letter] Ophthalmology 119 2012 2412
23. D.A. Mohammad, B.V. Sweet, and S.G. Elner Retisert: is the new advance in treatment of uveitis a good one? Ann Pharmacother 41 2007 449 454
24. L. Akduman, E.N. Cetin, and J. Levy et al. Spontaneous dissociation and dislocation of Retisert pellet [letter] Ocul Immunol Inflamm 21 2013 87 89